Ligand Pharmaceuticals, Inc. (LGND)
299.00
-17.13
(-5.42%)
USD |
NASDAQ |
Nov 05, 16:00
298.00
-1.00
(-0.33%)
After-Hours: 20:00
Ligand Pharmaceuticals Net Income (TTM) : 51.46M for Sept. 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 51.46M |
| June 30, 2026 | 197.22M |
| March 31, 2026 | 153.56M |
| December 31, 2025 | 124.45M |
| September 30, 2025 | 48.58M |
| June 30, 2025 | -75.86M |
| March 31, 2025 | -132.62M |
| December 31, 2024 | -4.032M |
| September 30, 2024 | 45.24M |
| June 30, 2024 | 42.14M |
| March 31, 2024 | 96.34M |
| December 31, 2023 | 53.82M |
| September 30, 2023 | 21.10M |
| June 30, 2023 | 41.02M |
| March 31, 2023 | 51.32M |
| December 31, 2022 | -5.219M |
| September 30, 2022 | 6.121M |
| June 30, 2022 | 10.20M |
| March 31, 2022 | 28.32M |
| December 31, 2021 | 59.36M |
| September 30, 2021 | 68.32M |
| June 30, 2021 | 47.89M |
| March 31, 2021 | 39.25M |
| December 31, 2020 | -2.985M |
| September 30, 2020 | -16.11M |
| Date | Value |
|---|---|
| June 30, 2020 | -24.66M |
| March 31, 2020 | -61.17M |
| December 31, 2019 | 629.30M |
| September 30, 2019 | 594.18M |
| June 30, 2019 | 676.80M |
| March 31, 2019 | 764.38M |
| December 31, 2018 | 143.32M |
| September 30, 2018 | 178.79M |
| June 30, 2018 | 119.86M |
| March 31, 2018 | 52.75M |
| December 31, 2017 | 12.55M |
| September 30, 2017 | 16.44M |
| June 30, 2017 | 9.062M |
| March 31, 2017 | -3.166M |
| December 31, 2016 | -2.368M |
| September 30, 2016 | 7.099M |
| June 30, 2016 | 205.21M |
| March 31, 2016 | 233.41M |
| December 31, 2015 | 227.44M |
| September 30, 2015 | 227.84M |
| June 30, 2015 | 29.45M |
| March 31, 2015 | 8.709M |
| December 31, 2014 | 10.90M |
| September 30, 2014 | 6.031M |
| June 30, 2014 | 7.219M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Johnson & Johnson | 16.10B |
| Eli Lilly & Co. | 27.58B |
| Merck & Co., Inc. | 2.449B |
| Indivior Pharmaceuticals, Inc. (DELISTED) | 450.00M |
| Bristol Myers Squibb Co. | 9.242B |